Novozymes A/S B (NZYMb)

498.2
+4.3(+0.87%)
  • Volume:
    195,281
  • Bid/Ask:
    0.0/0.0
  • Day's Range:
    492.8 - 500.6
  • Type:Equity
  • Market:Denmark
  • ISIN:DK0060336014
  • S/N:228256400

NZYMb Overview

Prev. Close
493.9
Day's Range
492.8-500.6
Revenue
14.56B
Open
496.4
52 wk Range
334.6-521.4
EPS
11.32
Volume
195,281
Market Cap
137.99B
Dividend (Yield)
5.25
(1.06%)
Average Vol. (3m)
342,912
P/E Ratio
43.32
Beta
0.76
1-Year Change
44.2%
Shares Outstanding
276,982,505
Next Earnings Date
Feb 01, 2022
What is your sentiment on Novozymes A/S B?
or
Market is currently closed. Voting is open during market hours.

Novozymes A/S B Company Profile

Industry
Chemicals
Sector
Materials
Employees
6369
Market
Denmark

Novozymes A/S produces and sells industrial enzymes and microorganisms in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company offers agriculture solutions, including crop production, and animal health and nutrition solutions; liquefaction, saccharifaction, fermentation, cellulosic hydrolysis, and process enhancement solutions for bioenergy; baking, beverages, dairy, starch, and protein ingredients for the food and beverage industry; and laundry, dishwashing, and professional cleaning solutions for the household care industry. It also provides wastewater solutions, such as additives, biogas production, industrial bio cleaning, compound removal, odor control, and system start-up solutions; and textile solutions comprising denim abrasion and finishing, biopreparation, biopolishing bleach clean-up, and desizing solutions. In addition, the company offers forest products that include bleach boosting, deinking, fiber modification, effluent control, pitch and stickies control, and starch modification products; and leather solutions, which comprise biopreparation, degreasing, and re-bating. Further, it provides pharmaceutical solutions, including lipases, immobilized lipases, and proteases for biocatalysis; and rTrypsin for cell culture. Novozymes A/S has collaboration with FMC Corporation to co-develop enzyme solutions. The company is based in Bagsvaerd, Denmark.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellStrong Buy
SummaryStrong BuyStrong BuyStrong BuyNeutralStrong Buy
  • any news on this? should I wait to buy cheaper?
    0
    • can you confirm the data for feb 14 2014? thank you.
      0
      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.